Free Trial

genedrive (GDR) Competitors

GBX 4.53
+0.48 (+11.87%)
(As of 07/17/2024 ET)

GDR vs. YGEN, VRCI, ABDX, GENI, PRM, LLAI, IDHC, DMTR, DXRX, and AGL

Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include Yourgene Health (YGEN), Verici Dx (VRCI), Abingdon Health (ABDX), GENinCode (GENI), Proteome Sciences (PRM), LungLife AI (LLAI), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), Diaceutics (DXRX), and ANGLE (AGL). These companies are all part of the "diagnostics & research" industry.

genedrive vs.

genedrive (LON:GDR) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, community ranking, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

genedrive has a net margin of 0.00% compared to Yourgene Health's net margin of -27.55%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
genedriveN/A -201.53% -74.09%
Yourgene Health -27.55%-27.06%-6.71%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
genedrive
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Yourgene Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

1.1% of genedrive shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 49.2% of genedrive shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

genedrive has higher earnings, but lower revenue than Yourgene Health. genedrive is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
genedrive£49K142.04-£5M-£0.04-112.75
Yourgene Health£29.67M0.55-£8.17M-£0.01-51.50

In the previous week, genedrive had 1 more articles in the media than Yourgene Health. MarketBeat recorded 1 mentions for genedrive and 0 mentions for Yourgene Health. genedrive's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company Overall Sentiment
genedrive Neutral
Yourgene Health Neutral

genedrive received 225 more outperform votes than Yourgene Health when rated by MarketBeat users. Likewise, 72.67% of users gave genedrive an outperform vote while only 53.13% of users gave Yourgene Health an outperform vote.

CompanyUnderperformOutperform
genedriveOutperform Votes
242
72.67%
Underperform Votes
91
27.33%
Yourgene HealthOutperform Votes
17
53.13%
Underperform Votes
15
46.88%

genedrive has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500. Comparatively, Yourgene Health has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.

Summary

Yourgene Health beats genedrive on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

GDR vs. The Competition

MetricgenedriveDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£6.96M£26.98M£5.26B£1.41B
Dividend Yield1.57%5.44%2.80%11.16%
P/E Ratio-112.75619.67128.831,692.15
Price / Sales142.041,637.792,279.23297,569.48
Price / Cash2.009.9534.7832.76
Price / Book4.513.004.962.78
Net Income-£5M£28.49M£109.62M£166.95M
7 Day Performance109.77%2.19%5.22%63.09%
1 Month Performance168.45%5.88%7.97%64.07%
1 Year Performance-69.53%-9.15%6.99%85.46%

genedrive Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
YGEN
Yourgene Health
0 of 5 stars
0.00 / 5 stars
N/AN/AN/A£16.43M£29.67M-51.50253
VRCI
Verici Dx
0 of 5 stars
0.00 / 5 stars
GBX 6.50
+4.0%
N/A-43.3%£15.77MN/A-130.0014Gap Up
ABDX
Abingdon Health
0 of 5 stars
0.00 / 5 stars
GBX 11.25
+2.3%
N/A+1.2%£14.26M£5.34M-1,125.0084Gap Up
GENI
GENinCode
0 of 5 stars
0.00 / 5 stars
GBX 6.25
flat
N/A-55.9%£11.06M£1.72M-104.1734News Coverage
Gap Down
PRM
Proteome Sciences
0 of 5 stars
0.00 / 5 stars
GBX 3.41
+1.5%
N/A-53.4%£10.07M£5.03M-341.0035News Coverage
Gap Up
LLAI
LungLife AI
0 of 5 stars
0.00 / 5 stars
GBX 14.50
flat
N/A-28.2%£4.45M£98,566.00-85.2915
IDHC
Integrated Diagnostics
0 of 5 stars
0.00 / 5 stars
GBX 0.31
flat
N/A-39.2%£1.83M£4.12B15.286,692
DMTR
Deepmatter Group
0 of 5 stars
0.00 / 5 stars
N/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
DXRX
Diaceutics
0 of 5 stars
0.00 / 5 stars
GBX 131
-0.4%
GBX 150
+14.5%
+55.3%£110.60M£21.90M10,500.00151
AGL
ANGLE
1.0099 of 5 stars
1.01 / 5 stars
GBX 15.25
+1.0%
GBX 70
+359.0%
+22.9%£39.74M£1.82M-169.44173

Related Companies and Tools

This page (LON:GDR) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners